Hussein Sultan

[Hussein Sultan @Husultan]

@SGoswamiMDPhD @DeblinaRC @RaiPratishtha @MDAndersonNews Congratulations, Sangeeta!

[Nan Zhang @NanZhangWistar]

With the acceptance of our lab's first paper and the receipt of new funding, I'm excited to share that we are hiring at least a new postdoc. Please RT. #postdoc #ovariancancer #myeloidcells #innateimmunity

https://t.co/2gPcGSSlzY

[Bernard A Fox @BernardAFox]

Nobel Lareate @JimAllisonPhD @MDAndersonNews talks about #CTLA4 and #ICOS /lots of background sprinkled with keen insights! Also some great unpublished data.- not posted here @PamSharmaMDPhD https://t.co/qIcIeBPGb3

[Journal of Experimental Medicine @JExpMed]

Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer. New study from Apostolia Tsimberidou, Farah Alayli, Kwame Okrah, Padmanee Sharma @PamSharmaMDPhD and colleagues @MDAndersonNews @parkerici: https://t.co/lmdXJ2vSkY

[ACIR @ACIR_org]

CD4+ Tr1 cells marked by LILRB4 suppress antitumor immunity – no Foxp3 needed. @WUSTLmed @husultan https://t.co/k1RMolhwHb

[Hussein Sultan @Husultan]

@SaligramaLab It is sad, but get ready for the 2025 :)

[Hussein Sultan @Husultan]

@Dohyun_Kim_PhD @washupathedu @NateraGenetics @parkerici Yes it was long but fun journey :)

[Hussein Sultan @Husultan]

I am pleased to share with you that my paper has been accepted in Nature https://t.co/7A7sIq0mgy
This work would not have been possible without the guidance of an exceptional mentor, support of awesome lab members and collaborators. @washupathedu @NateraGenetics @parkerici

[Hussein Sultan @Husultan]

@Hanzadatawfik @washupathedu @NateraGenetics @parkerici Thank you, Hanzada!

[Hussein Sultan @Husultan]

@SameerMalladi @washupathedu @NateraGenetics @parkerici Thank you, Sameer! You are next!

[Hussein Sultan @Husultan]

@Xiangyue_CA @washupathedu @NateraGenetics @parkerici Yup, finally!

[Hussein Sultan @Husultan]

@HebaAAttia @washupathedu @NateraGenetics @parkerici Thank you, Heba!

[Hussein Sultan @Husultan]

@SaligramaLab @WUSTLmed @WUSTLdbbs @WUSTLImmuno Thank you!

[John Connolly @John_E_Connolly]

Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance | Nature Reviews Cancer https://t.co/qhBg5O7w8N

[Maxim Artyomov @maxim_artyomov]

Take note of 1-day @NIHAging workshop on Heterogeneity of Aging this Fri, Jun 21 (9am ET, can be viewed on zoom). Many cool scientists including @AdamsBioAging @george_kuchel , Luigi Ferrucci, yours truly and many others!

Program and registration link:
https://t.co/vUW7pJVjIA

[The Colonna Lab @TheColonnaLab]

Happy to share our new study showing IL-22BP deficiency enhances gut microbiota's defense against infections. This boosts acetate production by Il22ra2–/–associated microbiota, suggesting IL-22BP as a therapeutic target. Led by @zefachi and @blandy https://t.co/TdX7GBGddO

[Hussein Sultan @Husultan]

@Dohyun_Kim_PhD Cool! It is very good news!

[Hussein Sultan @Husultan]

@aadel_chaudhuri @MayoClinic @MayoRadOnc @MayoCancerCare @n_laack @CherylWillmanMD Congratulations!!

[Hussein Sultan @Husultan]

@Dohyun_Kim_PhD I am sure, you will!!